SkinTumor-IBAM
Sponsor study identifier
observational
10
0 countries
N/A
Study Start
December 3, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
December 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 6, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Skin palpation remains, alongside visual inspection, the main clinical tool used to detect cutaneous abnormalities. However, palpation is a subjective, operator-dependent examination with limited sensitivity. There is currently no simple, real-time, low-cost, non-invasive tool available in routine clinical practice to objectively characterize the mechanical properties of skin tissue. The Impact-Based Analysis Method (IBAM) is a non-invasive biomechanical characterization technique developed by the MSME laboratory (Modélisation et Simulation Multi-Échelle, Université Paris Est Créteil) and the Mondor Institute for Biomedical Research (IMRB). It measures the mechanical response of soft tissue to a small mechanical impact, producing a quantitative indicator (Δt) that reflects local tissue stiffness. The reproducibility and sensitivity of this method have previously been demonstrated in preclinical models. This study aims to evaluate whether IBAM can distinguish malignant cutaneous tumors (basal cell carcinoma, squamous cell carcinoma, melanoma) from healthy surrounding skin based on their mechanical properties, and to characterize how these mechanical properties evolve from the tumor center toward clinically healthy margins. This is a prospective, single-center, ex vivo cohort study conducted at the Department of Plastic Surgery, Henri Mondor University Hospital (AP-HP), France. Patients undergoing surgical excision (with margins) for a suspected malignant cutaneous tumor will be included. Immediately after surgical excision, and before the specimen is sent for standard pathological examination, IBAM measurements will be performed ex vivo at three locations on the surgical specimen: the center of the tumor, the near peri-lesional area, and the distant peri-lesional area (presumed healthy margin). This additional step does not modify the patient's usual surgical or diagnostic management and does not require any additional intervention on the patient. The primary objective is to compare the IBAM-derived mechanical indicator (Δt) between malignant tissue and healthy tissue, using paired measurements from the same surgical specimen. The secondary objective is to describe the progressive change in mechanical properties from the tumor center to the healthy margin, which may help define more objective surgical safety margins in the future. A total of 10 patients will be included, based on a sample size calculation for a paired comparison (α = 5%, power = 80%). Statistical analysis will use paired Student's t-test or Wilcoxon signed-rank test, depending on data distribution (assessed by Shapiro-Wilk test). This research does not fall under the French "Loi Jardé" framework for research involving the human person, as it involves no additional intervention beyond standard care. It complies with the CNIL reference methodology MR-004. Patients receive individual written information and provide written consent or non-opposition prior to inclusion. Data are pseudonymized and securely stored. If confirmed, this method could provide surgeons with a simple, rapid, and objective tool to help differentiate malignant from healthy skin tissue intraoperatively, and to better define resection margins, with the ultimate goal of improving the surgical management of cutaneous malignancies.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 6, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 30, 2026
Actual (reported)October 6, 2026
Actual (reported)December 3, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 6, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Difference in the IBAM mechanical indicator (Δt) between malignant tumor tissue and healthy peri-lesional tissue
For each included surgical specimen, the IBAM indicator Δt (time interval between successive impactor rebounds, reflecting local tissue stiffness) is measured ex vivo at the center of the malignant tumor and at the distant peri-lesional area (clinically healthy margin). The paired difference in Δt between these two zones is calculated for each patient and compared across the cohort, to determine whether malignant and healthy cutaneous tissue can be mechanically differentiated using this indicator.
Measured on the day of surgery (ex vivo, immediately after surgical excision)
Spatial gradient of the IBAM mechanical indicator (Δt) from the tumor center to the healthy surgical margin
Measured on the day of surgery (ex vivo, immediately after surgical excision)
Patients with a suspected malignant cutaneous tumor (basal cell carcinoma, squamous cell carcinoma, or melanoma) undergoing surgical excision with safety margins at the Department of Plastic Surgery, Henri Mondor University Hospital. Immediately after excision, ex vivo biomechanical measurements are performed on the surgical specimen using the Impact-Based Analysis Method (IBAM) at three locations: the tumor center (malignant zone), the near peri-lesional area, and the distant peri-lesional area (healthy margin). No additional intervention is performed on the patient; standard surgical and pathological management is unchanged. Paired measurements from the same specimen are compared to assess whether IBAM can differentiate malignant from healthy cutaneous tissue based on mechanical properties, and to characterize how these properties evolve from the tumor toward healthy margins.
The study population consists of adult patients followed in the Department of Plastic, Reconstructive and Aesthetic Surgery at Henri Mondor University Hospital (AP-HP), France, who present with a cutaneous lesion clinically or dermoscopically suspicious for malignancy (basal cell carcinoma, squamous cell carcinoma, or melanoma) and for whom surgical excision with safety margins is indicated as part of standard care. Patients are identified during routine dermato-plastic surgical consultation ("carrefour dermatoplastique"). A total of 10 patients will be included at a single center, with an expected recruitment rate of approximately 2 to 6 patients per month.
Fujimoto Y, Yuri Y, Tamiya H. Skin mechanical properties measured with skin elasticity measurement device in patients with lymphedema: Scoping review. Skin Res Technol. 2024 Aug;30(8):e13861. doi: 10.1111/srt.13861.
Joodaki H, Panzer MB. Skin mechanical properties and modeling: A review. Proc Inst Mech Eng H. 2018 Apr;232(4):323-343. doi: 10.1177/0954411918759801. Epub 2018 Mar 5.
Bras MM, Radmacher M, Sousa SR, Granja PL. Melanoma in the Eyes of Mechanobiology. Front Cell Dev Biol. 2020 Feb 11;8:54. doi: 10.3389/fcell.2020.00054. eCollection 2020.
Ralph Goron, M.D.
CHU Henri Mondor, APHP
Romain Bosc, Ph.D.
CHU Henri Mondor, APHP
First Submitted
September 30, 2026
First Posted
October 6, 2026
Study Start
December 3, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
December 1, 2027
Contact the study team to confirm eligibility.
Taloni A, Alemi AA, Ciusani E, Sethna JP, Zapperi S, La Porta CA. Mechanical properties of growing melanocytic nevi and the progression to melanoma. PLoS One. 2014 Apr 7;9(4):e94229. doi: 10.1371/journal.pone.0094229. eCollection 2014.
Agache PG, Monneur C, Leveque JL, De Rigal J. Mechanical properties and Young's modulus of human skin in vivo. Arch Dermatol Res. 1980;269(3):221-32. doi: 10.1007/BF00406415.
Fujimoto Y, Yuri Y, Kato Y, Kinoshita S, Tamiya H. Intra- and inter-rater reliabilities of skin mechanical properties measured in healthy individuals using skin elasticity meter. Ann Med. 2023;55(2):2279747. doi: 10.1080/07853890.2023.2279747. Epub 2023 Nov 15.
Weder G, Hendriks-Balk MC, Smajda R, Rimoldi D, Liley M, Heinzelmann H, Meister A, Mariotti A. Increased plasticity of the stiffness of melanoma cells correlates with their acquisition of metastatic properties. Nanomedicine. 2014 Jan;10(1):141-8. doi: 10.1016/j.nano.2013.07.007. Epub 2013 Jul 24.
Park S, Chien AL, Brown ID, Chen J. Characterizing viscoelastic properties of human melanoma tissue using Prony series. Front Bioeng Biotechnol. 2023 Apr 6;11:1162880. doi: 10.3389/fbioe.2023.1162880. eCollection 2023.
Sarna M, Zadlo A, Hermanowicz P, Madeja Z, Burda K, Sarna T. Cell elasticity is an important indicator of the metastatic phenotype of melanoma cells. Exp Dermatol. 2014 Nov;23(11):813-8. doi: 10.1111/exd.12535. Epub 2014 Oct 10.
Woodtli V, Sachs D, Stracuzzi A, Robmann S, Biedermann T, Bottcher-Haberzeth S, Thumm B. A Method to Evaluate Skin and Skin Substitute Mechanical Properties Using a Suction Device. Methods Mol Biol. 2025;2922:297-304. doi: 10.1007/978-1-0716-4510-9_23.
Grahame R. A method for measuring human skin elasticity in vivo with observations of the effects of age, sex and pregnancy. Clin Sci. 1970 Aug;39(2):223-9. doi: 10.1042/cs0390223. No abstract available.
Bouffandeau A, Poisbleau D, Ouidja MOI, Karasinski P, Papy D, Flouzat-Lachaniette CH, Bosc R, Hersant B, Meningaud JP, Haiat G. Multimodal assessment of the skin biomechanical properties during wound healing and hyaluronic acid response. J Mech Behav Biomed Mater. 2026 Aug;180:107451. doi: 10.1016/j.jmbbm.2026.107451. Epub 2026 Apr 27.
Poudrel AS, Bouffandeau A, Demeet OL, Rosi G, Nguyen VH, Haiat G. Characterization of the concentration of agar-based soft tissue mimicking phantoms by impact analysis. J Mech Behav Biomed Mater. 2024 Apr;152:106465. doi: 10.1016/j.jmbbm.2024.106465. Epub 2024 Feb 16.
Bouffandeau A, Poudrel AS, Brossier C, Rosi G, Nguyen VH, Flouzat-Lachaniette CH, Meningaud JP, Haiat G. Assessment of the Mechanical Properties of Soft Tissue Phantoms Using Impact Analysis. Sensors (Basel). 2025 Feb 22;25(5):1344. doi: 10.3390/s25051344.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 6, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 6, 2026
Record last verified: 2026-09
Individual participant data will not be shared outside the investigator team. This is a small, single-center, exploratory study (n=10) using pseudonymized data with restricted access, in accordance with the information provided to participants at the time of consent. Aggregated, de-identified results will be made available through scientific publication.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: